Lite Strategy, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lite Strategy, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -90%In 3 years sales changed by -100% while total assets changed by -90%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Lite Strategy, Inc. made a loss over the last year. Lite Strategy, Inc. owes $0.02 for every $1 it owns. Lite Strategy, Inc. made a loss in the year to Jun 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Jun 2025.
P/E ratio
LossLite Strategy, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.64The share price is 0.64 times Lite Strategy, Inc.'s book value per share, lower than 87% of Healthcare companies in United States.
Market cap
$36 MThe total market value of all of Lite Strategy, Inc.'s shares at today's price (share price × number of shares), smaller than 78% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$57 MWhat Lite Strategy, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$1.87Net worth divided by the number of shares. The share price of $1.19 is 0.6 times this, which is the P/B above.
Return on equity (ROE)
-243.0%Lite Strategy, Inc. lost 243.0% of its shareholders' money over the last year, lower than 87% of Healthcare companies in United States.
Owes vs Owns
0.02×Lite Strategy, Inc. owes $0.02 for every $1 it owns (low), lower than almost all Healthcare companies in United States.
Dividend yield
NoneLite Strategy, Inc. does not currently pay a dividend.
Profit growth
LossLite Strategy, Inc. made a loss in the year to Jun 2025, after a profit the year before.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Lite Strategy, Inc.: $36 M ÷ $57 M (31 Mar 2026) = 0.6.
What is Lite Strategy, Inc.'s return on equity?
Lite Strategy, Inc. lost 243.0% of its shareholders' money over the last year, lower than 87% of Healthcare companies in United States.
How much does Lite Strategy, Inc. owe compared with what it owns?
Lite Strategy, Inc. owes $0.02 for every $1 it owns (low), lower than almost all Healthcare companies in United States.
Does Lite Strategy, Inc. pay a dividend?
No. Lite Strategy, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.